000			01749 a2200469 4500
005			20250515032205.0
264		0	_c20070223
008			200702s 0 0 eng d
022			_a0924-9338
024	7		_a10.1016/j.eurpsy.2006.04.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aPérez, M
245	0	0	_aAcetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia. Subanalysis of the active branch from Czech extended double blind study. _h[electronic resource]
260			_bEuropean psychiatry : the journal of the Association of European Psychiatrists _cDec 2006
300			_a548-50 p. _bdigital
500			_aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aCholinesterase Inhibitors _xtherapeutic use
650	0	4	_aCognition Disorders _xcomplications
650	0	4	_aCzech Republic
650	0	4	_aDonepezil
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIndans _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMemory _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aNeuropsychological Tests
650	0	4	_aPiperidines _xtherapeutic use
650	0	4	_aSchizophrenia _xcomplications
650	0	4	_aSchizophrenic Psychology
650	0	4	_aTreatment Outcome
700	1		_aTůma, I
700	1		_aPytela, O
700	1		_aKadlecová, E
700	1		_aZemanová, M
700	1		_aLenderová, Z
773	0		_tEuropean psychiatry : the journal of the Association of European Psychiatrists _gvol. 21 _gno. 8 _gp. 548-50
856	4	0	_uhttps://doi.org/10.1016/j.eurpsy.2006.04.008 _zAvailable from publisher's website
999			_c16391292 _d16391292